| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213670 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 8 Pages |
Abstract
PTV elimination and dose-reduction lowered the NTCP of the iPG, and PTV elimination lowered the NTCP of the cSMG. NTCP thresholds and the percentage of overlap of the PTV with organs at risk can predict which patients will benefit and inform future clinical trial design.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stuart E. MD, PhD, Avraham MD, FASTRO, Karen MS, Jae MD, PhD, Choonik PhD, Martha M. PhD, Randall K. PhD, FASTRO, FAAPM, Kristy K. PhD, FAAPM,